12:00 AM
 | 
Apr 10, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Avandia rosiglitazone: Marketed

Tulane University researchers published in the Journal of the American Medical Association data from a 348-patient U.S. study showing that the combination of Avandia...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >